The DOI matches its Crossref record; 100 of the 104 references it cites were found in a registry or an index.
The Dark Side of Testosterone Deficiency: II. Type 2 Diabetes and Insulin Resistance
Abstract
ABSTRACT: A considerable body of evidence exists suggesting a link among reduced testosterone plasma levels, type 2 diabetes (T2D), and insulin resistance (IR). Hypogonadal men are at higher risk for T2D. Here we evaluate the relationships between testosterone, metabolic syndrome (MetS), T2D, and IR and discuss the relationships among androgen deficiency and these factors, especially as it ultimately relates to the development of cardiovascular disease and erectile dysfunction (ED). Thus, a comprehensive literature search was carried out using PubMed, and relevant articles pertinent to androgen deficiency, T2D, IR, MetS, and ED were reviewed and discussed. Low testosterone precedes elevated fasting insulin, glucose, and hemoglobin A1c (HbA1C) values and may even predict the onset of diabetes. Treatment of prostate cancer patients with surgical or medical castration exacerbates IR and glycemic control, strengthening the link between testosterone deficiency and onset of T2D and IR. Androgen therapy of hypogonadal men improves insulin sensitivity, fasting glucose, and HbA1c levels. We suggest that androgen deficiency is associated with IR, T2D, MetS, and with increased deposition of visceral fat, which serves as an endocrine organ, producing inflammatory cytokines and thus promoting endothelial dysfunction and vascular disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This short summary clearly identifies androgens as anabolic hormones leading to storage of energy-rich substrates and calcium and phosphorus.”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [22]
Citations
Cites
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541
Insulin resistance and cardiovascular disease
Ginsberg, H. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10762 · Cited by 1,372
Ding, E. L., Song, Y., Malik, V. S., & Liu, S. (2006) · JAMA · doi:10.1001/jama.295.11.1288 · Cited by 1,354
Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’
Braun, M., Wassmer, G., Klotz, T., Reifenrath, B., Mathers, M. J., & Engelmann, U. H. (2000) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900622 · Cited by 996
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Prevalence of hypogonadism in males aged at least 45 years: the HIM study
MULLIGAN, T., FRICK, M. F., ZURAW, Q. C., STEMHAGEN, A., & MCWHIRTER, C. (2008) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00992.x · Cited by 767
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Leydig Cells: Endocrine, Paracrine, and Autocrine Regulation
Saez, J. M. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-5-574 · Cited by 637
Frequent Occurrence of Hypogonadotropic Hypogonadism in Type 2 Diabetes
Dhindsa, S., Prabhakar, S., Sethi, M., Bandyopadhyay, A., Chaudhuri, A., & Dandona, P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0804 · Cited by 631
Stellato, R. K., Feldman, H. A., Hamdy, O., Horton, E. S., & McKinlay, J. B. (2000) · Diabetes Care · doi:10.2337/diacare.23.4.490 · Cited by 618
Flagged first, then by citations
4 of the 104 references couldn’t be matched to a known paper.
Research works printed but not linked: 6
- 10.1210/en.140.11.4939 · DOI
- 10.1210/jc.82.6.1807 · DOI
- 10.1210/jc.84.10.3673 · DOI
- 10.1210/jc.81.3.1018 · DOI · Paper page
- 10.1210/jc.86.10.4913 · DOI
- 10.1210/jc.80.2.654 · DOI · Paper page
Cited by
Sorted by citations
Items 201–261 of 261
Benefits and Risks of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M., & Morgentaler, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813197-8.00018-x · Cited by 2
Self-citationHormone Replacement Therapy with Testosterone
Bassas, L., & Resmini, E. (2013) · Springer eBooks · doi:10.1007/978-3-642-37393-0_173-1 · Cited by 1
Murakami, R., Ohsaki, Y., Ito, H., Ho, H., Agista, A. Z., Chiang, Y., Chen, Y.-L., Maekawa, M., Hirose, T., Hara, K., et al. (2026) · Foods · doi:10.3390/foods15061070 · Cited by 1
Die antiandrogene Therapie aus urologischer Sicht
Korda, J. B., & Sommer, F. O. (2010) · Forensische Psychiatrie Psychologie Kriminologie · doi:10.1007/s11757-010-0054-7 · Cited by 1
androgen-deprivation-therapy-and-cardiovascular-risk/#
Rees, J. R. E. (2017) · Cancer Studies and Therapeutics · doi:10.31038/cst.2017272 · Cited by 1
Medical Management of Sexual Dysfunction in the Aging Male
Rubin, R. S., & Goldstein, I. (2016) · Topics in Geriatric Rehabilitation · doi:10.1097/tgr.0000000000000106 · Cited by 1
Lioudaki, E., & Whyte, M. (2016) · Clinical Case Reports · doi:10.1002/ccr3.686 · Cited by 1
Testicular and thyroid function as survival predictors in the elderly patient candidate to surgery
Aversa, A., & Fabbri, A. (2017) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2017.841 · Cited by 1
Karampela, D. S., Giannopoulou, P. C., Νάτσος, Α., Margos, N. P., Zvintzou, E., & Kypreos, K. E. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0010 · Cited by 1
Laskin, G. R., Steiner, J. L., Berryman, C. E., & Gordon, B. S. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.10.005 · Cited by 1
Kim, K. (2013) · Korean Journal of Family Practice · Cited by 1
Roles of Testosterone in Men with Type 2 Diabetes: A Review
Thanh, T. N., & Luu, P. D. (2014) · World Congress on Medical Physics and Biomedical Engineering, September 7 - 12, 2009, Munich, Germany · doi:10.1007/978-3-319-11776-8_68 · Cited by 1
Journal, B. S., Karawi, I. N. A., & Jassim, N. A. (2013) · Baghdad Science Journal · doi:10.21123/bsj.10.3.945-953 · Cited by 1
Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks
Hassanabad, M. F., & Fatehi, M. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180731125724 · Cited by 1
The Complex Relationship Between Erectile Dysfunction and Hypogonadism in Diabetes Mellitus
Holland, L. C., Beilan, J. A., Tatem, A. J., & Lipshultz, L. I. (2019) · Current Sexual Health Reports · doi:10.1007/s11930-019-00216-9 · Cited by 1
HASAN, B. F., Al-Karawi, I. N., & Jassim, N. A. (2024) · Baghdad Science Journal · doi:10.21123/bsj.2013.10.3.945-953 · Cited by 1
TOMBAL, B. F. (2008) · European Urology · doi:10.1016/j.eururo.2008.09.026 · Cited by 1
Lee, O. D. (2011) · American Journal of Men s Health · doi:10.1177/1557988311416633 · Cited by 1
Hormone Replacement Therapy with Testosterone and the Vascular System
Bassas, L., & Resmini, E. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_173
Obesity, metabolic syndrome, male hypogonadism and cardiovascular risk
Corona, G., Lotti, F., Sforza, A., Maggi, M., & Chiarini, V. (2009) · Italian Journal of Medicine · doi:10.1016/j.itjm.2009.09.002
Association between androgen deficiency and metabolic syndrome in men with type 2 diabetes mellitus
Mohieldein, A., Alzohairy, M. A., & Hasan, M. (2014) · International Journal of Biomedical Research · doi:10.7439/ijbr.v5i3.535
Prieto-Castro, R., Bonilla-Parrilla, R., Villalta, E. J., Martínez, J. S., & Martín‐Morales, A. (2014) · Revista Internacional de Andrología · doi:10.1016/j.androl.2013.12.003
Hipogonadismo: nueva propuesta de clasificación basada en el mecanismo inductor
Arcila, J. F. U. (2014) · Revista Urología Colombiana / Colombian Urology Journal · doi:10.1016/s0120-789x(14)50038-x
Farrell, J. A. B., Deshmukh, A., & Baghaie, A. A. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.59
Testosterone and Its Association with Metabolic and Cardiovascular Disease
Corona, G., Rastrelli, G., & Maggi, M. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_5
Lowrance, K., & Sapp, A. (2014) · The JBI Database of Systematic Reviews and Implementation Reports · doi:10.11124/jbisrir-2014-1735
Soejono, W. D. M. R. S. K. (2015) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran)
Tishova, Y. A., & Kalinchenko, S. Y. (2009)
García-Cruz, E., Gosálbez, D., Sallent, A., Piqueras, M., Leibar-Tamayo, A., Otero, J., Castañeda-Argáiz, R., Carrión, A., Asiaín, I., Arrom, L. M., et al. (2014) · Journal of Men s Health · doi:10.1089/jomh.2014.0021
Murphy, R. M. (2011) · Library and Archives Canada (Government of Canada)
Garcia-Banigan, D. C., Guay, A. T., TRAISH, A. M., Doros, G. D., & Gawoski, J. M. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0027
Self-citationHeidelbaugh, J., Grech, A., & Miner, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-26091-4_13
Testosterone and Risk Factors in the Metabolic Syndrome: Implications for Erectile Dysfunction
Guay, A. T., & Traish, A. M. (2011)
Self-citationRELATION BETWEEN BLOOD GROUPS ABO & RH IN PATIENTS DIABETIC
Tavasolian, F., Abdolahi, E., Vakili, M., & Amini, A. (2014)
Effects of Lifestyle Changes and Testosterone Therapy on Erectile Function
Traish, A. M., & Trussler, J. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-31587-4_8
Self-citationTraish, A. M., Saad, F., Feeley, R. J., & Guay, A. T. (2009) · Journal of Men s Health · doi:10.1016/j.jomh.2009.08.032
Self-citationKhripun, I., Белоусов, И. И., Vorobyev, S., Пузырева, В. П., Сергеевна, А. Я., Ibishov, H., & Коган, М. И. (2016) · Medical news of the North Caucasus · doi:10.14300/mnnc.2016.11140
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Hipogonadismo associado à obesidade: efeitos do tratamento com citrato de clomifeno
Soares, A. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-13062018-074535
Analytical Method Validation of Testosterone Undecanoate Soft Gelatin Capsule by RP-HPLC Method
Islam, M. D. M. D., Mehedi Hasan, M., Mohiuddin, T., Hassan, M. M., Latif, A., & Haque, P. (2018) · Journal of Developing Drugs · doi:10.4172/2329-6631.1000184
Exercise Training, Immobilisation and Castration Effects on Skeletal Muscle Na+,K+-ATPase
Altarawneh, M. M. (2018) · Victoria University Research Repository (Victoria University)
TESTOSTERONE LEVEL IN TYPE 2 DIABETIC MALE PATIENTS
Mustafa, H. M., Fattah, F., & Salih, I. (2020) · Journal of Sulaimani Medical College · doi:10.17656/jsmc.10235
Risal, P., Maharjan, A., Bhatt, R. D., & Tamrakar, D. (2020) · Kathmandu University Medical Journal · doi:10.3126/kumj.v18i3.49229
Pavlova, Z. S., Иванович, Г. И., Orlova, Y. A., & Kamalov, A. A. (2021) · Obesity and metabolism · doi:10.14341/omet12733
Metabolic Syndrome Impairs Erectile Function
Fried, R. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-420046-3.00005-6
Khripun, I., Белоусов, И. И., Vorobyev, S., Пузырева, В. П., Сергеевна, А. Я., Ibishov, H., & Коган, Е. А. (2016) · Medical news of the North Caucasus · doi:10.14300/mnnc.2016.00140
Cleffi, S., Neto, A. S., Reis, L. O., Maia, P., Fonseca, F. L. A., Wroclawski, M. L., Neves, M., Pompeo, A. C. L., Giglio, A. D., Faria, E. F., et al. (2011) · Actas Urológicas Españolas · doi:10.4321/s0210-48062011000500002
High Doses of Testosterone Has Destructive Effects on Normal Cell Line in Cell Culture
(2016) · International Conference on Advances in Agricultural, Biological & Environmental Sciences (AABES) · doi:10.15242/iicbe.c1216039
Effect of Metabolic Syndrome in Patients with Prostate Cancer (Review)
Peshkov, M. N., Peshkova, G. P., & Reshetov, I. V. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.105357
Issa, H. H., & Mohammad, M. K. Q. (2022) · Journal of Wasit for Science and Medicine · doi:10.31185/jwsm.213
Mukta, U. S. (2024) · Journal of Diabetes Metabolic Disorders & Control · doi:10.15406/jdmdc.2024.11.00281
Preclinical Investigation into the Anti-hypogonadism Effects of Panax ginseng Root
Sharma, S., Kumar, J., Lakhanpal, A., & Ritu (2025) · Current Bioactive Compounds · doi:10.2174/0115734072374645250531084028
History of Testosterone Therapy in Men with Testosterone Deficiency: 1939–2024
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_14
Self-citationLiang, A., Cao, X., Xin-Xin, R., Lan, K., Dan, Z., & Chang, X. (2025) · Journal of Medical Biochemistry · doi:10.5937/jomb0-58894
Gupta, H., Singh, R., Singh, K., Gupta, M., Kaur, J., Singla, M., & Garg, S. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_842_25
He, Q., Xu, Y.-Y., Tan, X., & Yin, Y. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02321-y
Falkenbach, F., Al‐Monajjed, R., Reimold, P., Huber, J., & Carlsson, S. (2026) · Die Urologie · doi:10.1007/s00120-026-02865-w
Vardar, D. Ö., Tutkun, L., İritaş, S. B., Gözükara, M. G., Abuşoğlu, G., Deniz, S., Türksoy, V. A., & Tutkun, E. (2026) · BMC Endocrine Disorders · doi:10.1186/s12902-026-02605-3
Zitzmann, M., Bosnyák, Z., Jones, R. L., & Caliber, M. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71384
Evidências da associação entre testosteronas e doença periodontal no sexo masculino
Steffens, J. P. (2013) · Americanae (AECID Library)
Metadata
- Authors
- Traish, A. M., Saad, F., & Guay, A.
- Affiliations
- Gulf Medical University (AE)
- ORCID
- Saad, Farid
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2009-01-02
- Volume
- 30
- Issue
- 1
- Pages
- 23-32
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W2070295872
- Cited by
- 266
- References
- 104
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 8 · 2018: 12 · 2017: 16 · 2016: 24 · 2015: 17 · 2014: 31 · 2013: 17 · 2012: 21
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Andrology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- School of Medicine, Boston University
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- androgen deficiency, hypogonadism, type 2 diabetes, insulin resistance, metabolic syndrome, erectile dysfunction, cardiovascular disease, castration, androgen therapy, visceral fat, endothelial dysfunction, inflammatory cytokines, glycemic control
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypogonadism, Erectile Dysfunction, Insulin Resistance, Male, Testosterone, Vascular Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
